1.Immunoproteomic assay of secretive proteins from Streptococcus suis type 2 strain SC84.
Qiang-Zheng SUN ; Xia LUO ; Chang-Yun YE ; Di XIAO ; Han ZHENG ; Huai-Qi JING ; Jian-Guo XU
Chinese Journal of Epidemiology 2008;29(3):267-271
OBJECTIVETo identify antigenic proteins secreted by Streptococcus suis (S. suis) type 2 strain SC84.
METHODSTwo-dimensional electrophoresis (2-DE), western-blot assay and matrix-assisted laser desorption/ionization-time of flight-mass spectrometry (MALDI-TOF-MS) analysis were performed to search and identify antigenic proteins secreted by S. suis strain SC84, which triggered an outbreak of the disease in Sichuan province,China, in 2005.
RESULTSA total number of 14 western blot spots were found on PVDF membrane. 11 spots which could be found the existence of matching protein on coomassie G-250-stained 2-DE gel were identified by MALDI-TOF MS. The 11 proteins, all located at extra-cellular or cell wall, were classified into 8 kinds of proteins. Among of them, muramidase-released protein (MRP), suilysin (Sly) and extra-cellular factor (EF) were the known antigenic proteins, but several proteins such as putative 5'-nucleotidase, ribo-nucleases G and E, and predicted metal-loendo-peptidase were newly found antigenic proteins. All the identified protein were found to have had the coding gene in genomic of S. suis strain 05ZYH33, isolated from patients in Sichuan province, China in 2005.
CONCLUSIONThe newly found proteins could be used as voluntary antigens for detection and vaccination of S. suis.
Bacterial Proteins ; analysis ; immunology ; Humans ; Proteomics ; Streptococcal Infections ; Streptococcus suis ; immunology ; isolation & purification ; metabolism
2.Reconstruction of Leptospira interrogans lipL21 gene and characteristics of its expression product.
Dong-jiao LUO ; Ye HU ; R H DENNIN ; Jie YAN
Journal of Zhejiang University. Medical sciences 2007;36(5):458-464
OBJECTIVETo reconstruct the nucleotide sequence of Leptospira interrogans lipL21 gene for increasing the output of prokaryotic expression and to understand the changes on immunogenicity of the expression products before and after reconstruction, and to determine the position of envelope lipoprotein LipL21 on the surface of leptospiral body.
METHODSAccording to the preferred codons of E.coli, the nucleotide sequence of lipL21 gene was designed and synthesized, and then its prokaryotic expression system was constructed. By using SDS-PAGE plus BioRad agarose image analysor, the expression level changes of lipL21 genes before and after reconstruction were measured. A Western blot assay using rabbit anti-TR/Patoc I serum as the first antibody was performed to identify the immunoreactivity of the two target recombinant proteins rLipL21s before and after reconstruction. The changes of cross agglutination titers of antisera against two rLipL21s before and after reconstruction to the different leptospiral serogroups were demonstrated using microscope agglutination test (MAT). Immuno-electronmicroscopy was applied to confirm the location of LipL21s.
RESULTThe expression outputs of original and reconstructed lipL21 genes were 8.5 % and 46.5 % of the total bacterial proteins, respectively. Both the two rLipL21s could take place immune conjugation reaction with TR/Patoc I antiserum. After immunization with each of the two rLipL21s in rabbits, the animals could produce specific antibody. Similar MAT titers with 1:80 - 1:320 of the two antisera against rLipL21s were present. LipL21 was confirmed to locate on the surface of leptospiral envelope.
CONCLUSIONLipL21 is a superficial antigen of Leptospira interrogans. The expression output of the reconstructed lipL21 gene is remarkably increased. The expression rLipL21 maintains fine antigenicity and immunoreactivity and its antibody still shows an extensive cross immunoagglutination activity. The high expression of the reconstructed lipL21 gene will offer a favorable condition to use its product for further developing a novel universal vaccine as well as detection kit of leptospirosis.
Amino Acid Sequence ; Animals ; Antigens, Bacterial ; genetics ; immunology ; metabolism ; Bacterial Outer Membrane Proteins ; genetics ; immunology ; metabolism ; Bacterial Vaccines ; immunology ; Base Sequence ; Blotting, Western ; Cloning, Molecular ; Electrophoresis, Polyacrylamide Gel ; Escherichia coli ; genetics ; Immune Sera ; immunology ; Leptospira interrogans ; genetics ; immunology ; ultrastructure ; Lipoproteins ; genetics ; immunology ; metabolism ; Microscopy, Immunoelectron ; Molecular Sequence Data ; Rabbits ; Recombinant Fusion Proteins ; genetics ; immunology ; metabolism ; Sequence Analysis, DNA ; Vaccines, DNA ; immunology
3.Comparison of Two Enzyme Immunoassay for Detection of Clostridium difficile Toxin A and Toxin B.
Bo Moon SHIN ; Soo Jin YOO ; Hye Jun OH
The Korean Journal of Laboratory Medicine 2009;29(2):122-126
BACKGROUND: Enzyme immunoassay (EIA) capable of detecting both toxin A and toxin B is strongly recommended for the diagnosis of Clostridium difficile associated disease. Therefore, we evaluated two different EIAs for the detection of C. difficile toxin A/B. METHODS: For a total of 228 stool specimens we performed bacteriologic cultures for C. difficile and examined for toxin A and toxin B using enzyme linked fluorescent immunoassay (ELFA; VIDAS CDAB, Bio-Merieux sa, France) and ELISA (C.DIFFICILE TOX A/B II, TECHLAB, USA). We also performed PCR assays for toxin A and B genes in 117 C. difficile isolates that grew from the stool cultures and compared the results with those obtained with the two different EIAs. RESULTS: The concordance rate between ELFA and ELISA was 85.5% (195/228). Using the culture and PCR results as the standard, the sensitivity/specificity of the ELFA and ELISA were 65.0%/72.1% and 71.8%/70.3%, and for positive/negative predictive values were 78.4%/69.6% and 71.8%/70.3%, respectively (P value >0.05). No differences were observed between the results of ELFA and ELISA with toxin A- toxin B+ strains of C. difficile. CONCLUSIONS: The sensitivity of the ELISA was slightly higher than that of ELFA for toxin A and toxin B, but the specificity and positive predictive value of the ELFA were rather higher than those of the ELISA, although no statistical differences were observed. A bacteriologic culture and PCR assay for toxin genes are recommended in case the both EIAs are negative.
Bacterial Proteins/*analysis/genetics/immunology
;
Bacterial Toxins/*analysis/genetics/immunology
;
Clostridium difficile/genetics/isolation & purification/*metabolism
;
Enterotoxins/*analysis/genetics/immunology
;
Enzyme-Linked Immunosorbent Assay/*methods
;
Feces/microbiology
;
Fluorescent Dyes/chemistry
;
Humans
;
Reagent Kits, Diagnostic
4.Recent Trends of Antigenic Variation in Bordetella pertussis Isolates in Korea.
So Hyun KIM ; Jin LEE ; Hwa Young SUNG ; Jae Yon YU ; Seong Han KIM ; Mi Sun PARK ; Sang Oun JUNG
Journal of Korean Medical Science 2014;29(3):328-333
Pertussis is a representative vaccine-preventable disease. However, there have been recent outbreaks in countries where even higher vaccination against the disease. One reason is the emergence of antigenic variants, which are different to vaccine type. In Korea, reported cases have rapidly increased since 2009. Therefore, we analyzed genotype of strains isolated in 2011-2012 by multilocus sequence typing method. As expected, the genotype profiles of tested genes dramatically changed. The major sequence type changed from ST1 to ST2, and new sequence type (ST8) appeared. In the minimum spanning tree, recent isolates belonging to the ACC-I-ST3 subgroup were detected that were composed of ST2, ST3, and ST6. In particular, the ST2 frequency increased to 81%. The novel ST8 was linked to the increased frequency of ST2. In addition, toxic strains carrying the ptxP3 promoter type were confirmed. This ptxP3 type emerged from 2009 and its frequency had increased to 100% in 2012. Based on these results, it can be inferred that the genotypic changes in the currently circulating strains are strongly associated with the recent increasing of pertussis in Korea. Therefore, the surveillance system should be strengthened, and genetic characterization of the isolates should be expanded to the whole genome sequence level.
*Antigenic Variation
;
Antigens/*genetics/immunology/metabolism
;
Bacterial Proteins/genetics/metabolism
;
Bordetella pertussis/*genetics/isolation & purification/*metabolism
;
Genes, Bacterial
;
Genotype
;
Humans
;
Pertussis Toxin/genetics/metabolism
;
Promoter Regions, Genetic
;
Republic of Korea
;
Sequence Analysis, DNA
;
Whooping Cough/immunology/*microbiology/pathology
5.Construction, expression and identification of a recombinant BCG vaccine encoding human Mycobacterium tuberculosis heat shock protein 65.
Wuxing DAI ; Liang LIANG ; Hong GAO ; Hailang HUANG ; Zhihao CHEN ; Jizhong CHENG ; Yongmu HUANGFU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2004;24(2):107-123
Heat shock protein 65 (HSP65) is one of the most important protective immunogens against the tuberculosis infection. The signal sequence of antigen 85B and the whole HSP65 DNA sequence of human Mycobacterium tuberculosis (M. tuberculosis) were amplified from BCG genome and plasmid pCMV-MTHSP65 respectively by polymerase chain reactions (PCR). These two sequences were cloned into the plasmid pBCG-2100 under the control of the promoter of heat shock protein 70 (HSP70) from human M. tuberculosis, yielding the prokaryotic shuttle expression plasmid pBCG-SP-HSP65. Results of restriction endonuclease analysis, PCR detection and DNA sequencing analysis showed that the two cloned DNA sequences were consistent with those previously reported, and the direction of their inserting into the recombinant was correct and the reading frame had been maintained. The recombinants were electroporated into BCG to construct the recombinant BCG vaccine and induced by heating. The induced expression detected by SDS-PAGE showed that the content of 65 kD protein expressed in recombinant BCG was 35.69% in total bacterial protein and 74.09% in the cell lysate supernatants, suggesting that the recombinant HSP65 gene could express in BCG with high efficiency and the expressed proteins were mainly soluble. Western-blot showed that the secretive recombinant proteins could specifically combine with antibody against M. tuberculosis HSP65, indicating that the recombinant proteins possess the biological activity of HSP65.
BCG Vaccine
;
biosynthesis
;
immunology
;
Bacterial Proteins
;
biosynthesis
;
immunology
;
Chaperonin 60
;
Chaperonins
;
biosynthesis
;
immunology
;
Cloning, Molecular
;
Escherichia coli
;
metabolism
;
Genetic Vectors
;
Humans
;
Mycobacterium tuberculosis
;
genetics
;
immunology
;
Plasmids
;
genetics
;
Sequence Analysis, DNA
;
Vaccines, Synthetic
;
biosynthesis
;
immunology
6.Inflammatory reaction and alterations of pulmonary surfactant in Pseudomonas Aeruginosa pneumonia in immunocompromised rats.
Jieming QU ; Zhuozhe LI ; Lixian HE ; Bo SUN ; Xuehua CHEN
Chinese Medical Journal 2002;115(7):1099-1100
Pulmonary surfactant ( PS ) compromises lipids and surfactant proteins (SP) and lines on the alveolar air-liquid interface. It can reduce surface tension, prevent alveoli from collapse and reduce alveoli edema by disaturated dipalmitoylphosphatidylcholine. It also modulates the pulmonary immunology by SP-A and SP-D. In this study,we established a rat model of immunocompromised host (ICH) with pulmonary infection of Pseudomonas aeruginosa (P. aeruginosa), then studied its pulmonary inflammatory reaction and analyzed the concentration of lipids and SP-A in bronchoalveolar lavage fluid (BALF) during infection.
Animals
;
Bronchoalveolar Lavage Fluid
;
chemistry
;
microbiology
;
Lipids
;
analysis
;
Lung
;
microbiology
;
Male
;
Neutrophils
;
physiology
;
Pneumonia, Bacterial
;
immunology
;
metabolism
;
Proteolipids
;
analysis
;
Pseudomonas Infections
;
immunology
;
metabolism
;
Pulmonary Surfactant-Associated Protein A
;
Pulmonary Surfactant-Associated Proteins
;
Pulmonary Surfactants
;
analysis
;
Rats
;
Rats, Sprague-Dawley
7.Correlations between the CagA Antigen and Serum Levels of Anti-Helicobacter pylori IgG and IgA in Children.
Ji Hyun SEO ; Chun Woo LIM ; Ji Sook PARK ; Jung Sook YEOM ; Jae Young LIM ; Jin Su JUN ; Hyang Ok WOO ; Hee Shang YOUN ; Seung Chul BAIK ; Woo Kon LEE ; Myung Je CHO ; Kwang Ho RHEE
Journal of Korean Medical Science 2016;31(3):417-422
We tested correlations between anti-Helicobacter pylori IgG and IgA levels and the urease test, anti-CagA protein antibody, degree of gastritis, and age. In total, 509 children (0-15 years) were enrolled. Subjects were stratified as 0-4 years (n = 132), 5-9 years (n = 274), and 10-15 years (n = 103) and subjected to the urease test, histopathology, ELISA, and western blot using whole-cell lysates of H. pylori strain 51. The positivity rate in the urease test (P = 0.003), the degree of chronic gastritis (P = 0.021), and H. pylori infiltration (P < 0.001) increased with age. The median titer for anti-H. pylori IgG was 732.5 IU/mL at 0-4 years, 689.0 IU/mL at 5-9 years, and 966.0 IU/mL at 10-15 years (P < 0.001); the median titer for anti-H. pylori IgA was 61.0 IU/mL at 0-4 years, 63.5 IU/mL at 5-9 years, and 75.0 IU/mL at 10-15 years (P < 0.001). The CagA-positivity rate was 26.5% at 0-4 years, 36.5% at 5-9 years, and 46.6% at 10-15 years for IgG (P = 0.036), and 11.3% at 0-4 years, 18.6% at 5-9 years, and 23.3% at 10-15 years for IgA (P < 0.001). Anti-H. pylori IgG and IgA titers increased with the urease test grade, chronic gastritis degree, active gastritis, and H. pylori infiltration. Presence of CagA-positivity is well correlated with a high urease test grade and high anti-H. pylori IgG/IgA levels.
Adolescent
;
Antibodies, Bacterial/*blood
;
Antigens, Bacterial/*analysis/immunology
;
Bacterial Proteins/*analysis/immunology/metabolism
;
Blotting, Western
;
Child
;
Child, Preschool
;
Chronic Disease
;
Enzyme-Linked Immunosorbent Assay
;
Female
;
Gastritis/pathology
;
Helicobacter Infections/blood/microbiology/*pathology
;
Helicobacter pylori/isolation & purification/*metabolism
;
Humans
;
Immunoglobulin A/*blood
;
Immunoglobulin G/*blood
;
Infant
;
Infant, Newborn
;
Male
;
Severity of Illness Index
;
Urease/metabolism
8.Molecular heterogeneity of plpE gene in Indian isolates of Pasteurella multocida and expression of recombinant PlpE in vaccine strain of P. multocida serotype B: 2.
Ajay Pratap SINGH ; Satparkash SINGH ; Rajeev RANJAN ; Santosh Kumar GUPTA ; Vijendra Pal SINGH ; Bhaskar SHARMA
Journal of Veterinary Science 2010;11(3):227-233
Outer membrane proteins of Pasteurella (P.) multocida have been known to be protective immunogens. Pasteurella lipoprotein E (PlpE) has been reported to be an important cross reactive outer membrane protein in P. multocida. The gene encoding the PlpE of P. multocida serotypes A: 3, B: 2 and D: 1 was amplified from the genomic DNA. The amplified products were cloned and the nucleotide sequence was determined. Sequence analysis of the recombinant clones revealed a single open reading frame of 1,011 bp, 1,008 bp and 1,017 bp encoding a protein with a calculated molecular mass of 37.829 kDa, 37.389 kDa and 37.965 kDa for serotypes A: 3, B: 2 and D: 1 respectively. The comparison of the plpE sequence in different capsular types revealed a high degree (>90%) of homology. Furthermore, the plpE gene of Haemorhhagic septicaemia causing serotype (B: 2) was expressed in E. coli and recombinant PlpE was strongly immunostained by antiserum against whole cell antigen, indicating that the protein is expressed in vivo.
Animals
;
Bacterial Outer Membrane Proteins/*genetics/immunology/metabolism
;
Base Sequence
;
Blotting, Western
;
Cattle
;
Cattle Diseases/*microbiology
;
Cloning, Molecular
;
Electrophoresis, Polyacrylamide Gel
;
Escherichia coli
;
*Genetic Variation
;
Hemorrhagic Septicemia/microbiology/*veterinary
;
India
;
Lipoproteins/*genetics/immunology/metabolism
;
Molecular Sequence Data
;
Open Reading Frames/genetics
;
Pasteurella multocida/*genetics/immunology
;
Sequence Analysis, DNA
;
Sequence Homology
;
Serotyping
;
Species Specificity